Antiphospholipid Antibodies and Systemic Scleroderma

Objective: Antiphospholipid antibodies (APLs) could be associated with an increased risk of vascular pathologies in systemic scleroderma. The aim of our study was to search for APLs in patients affected by systemic scleroderma and to evaluate their involvement in the clinical manifestations of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Touré, Awa Oumar, Ly, Fatimata, Sall, Abibatou, Diatta, Alassane, Gadji, Macoura, Seck, Moussa, Faye, Blaise, Dieye, Tandakha, Diop, Saliou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781654/
https://www.ncbi.nlm.nih.gov/pubmed/24385750
http://dx.doi.org/10.4274/tjh.2012.0059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781654/
https://www.ncbi.nlm.nih.gov/pubmed/24385750
http://dx.doi.org/10.4274/tjh.2012.0059

Ejemplares similares